2Q FY26: QUARTERLY ACTIVITIES & CASHFLOW REPORT HeraMED Limited (ASX:HMD) (‘HeraMED’ or the ‘Company’), a medical data and technology company leading the digital transformation of women and maternity care, is pleased to provide its Appendix 4C cashflow statement for the June...
Quarterly Activities & Cashflow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from HeraMED
- HeraMED successfully completes Phase 1 pilot with Lee Health
- Preliminary Final Report
- HeraMED completes $3.2 million placement
- Trading Halt
- HeraMED partners with Lee Health- digital maternity solution
Later from HeraMED
- Resignation and Appointment of Joint Company Secretary
- Appendix 4D and Half Year Report
- Notification regarding unquoted securities - HMD
- Lee Health Approves Expansion of HeraMED Maternity Program
- HeraMED Wins People's Choice at 2026 Garmin Health Awards
Follow HeraMED into a list and get an email when it puts out news.
Follow HeraMED